All In Biotech

Drug Trial Radar · NCT02584244

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Aug 4, 2016

Primary completion

Feb 2027

Study completion Apr 2027

Sponsor

Lead sponsor
Lumicell, Inc.Industry
Sponsor type
Industry
Collaborators
National Cancer Institute (NCI)
First posted
Oct 22, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.

Conditions

  • Colorectal Cancer
  • Pancreatic Cancer
  • Esophageal Cancer
  • Gastric Cancer

Interventions

  • LUM015Drug

  • LUM 2.6 Imaging DeviceDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlate LUM015 fluorescence in gastrointestinal cancers (pancreatic, esophageal, and colorectal) with pathology resultsTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Massachusetts General Hospital

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.